Results 121 to 130 of about 188,723 (351)
MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY
Mucolytic drugs, particularly, direct action mucolytics with acetylcysteine derivatives among them, are included in the complex therapy of the bronchopulmonary dysplasia exacerbations.
I. V. Davydova+3 more
doaj +1 more source
Lung interstitial cells during alveolarization [PDF]
Recent progress in neonatal medicine has enabled survival of many extremely low-birth-weight infants. Prenatal steroids, surfactants, and non-invasive ventilation have helped reduce the incidence of the classical form of bronchopulmonary dysplasia ...
Chang Won Choi
doaj +1 more source
ERCPMP: An Endoscopic Image and Video Dataset for Colorectal Polyps Morphology and Pathology [PDF]
In the recent years, artificial intelligence (AI) and its leading subtypes, machine learning (ML) and deep learning (DL) and their applications are spreading very fast in various aspects such as medicine. Today the most important challenge of developing accurate algorithms for medical prediction, detection, diagnosis, treatment and prognosis is data ...
arxiv
Efficacy of Hydrocortisone Compared to Dexamethasone in the Prevention of BPD Without Impending Neurodevelopment in Infant Patients Born at Less Than 30 Weeks Gestational Age [PDF]
Introduction: Bronchopulmonary dysplasia (BPD) is a manifestation of neonatal respiratory distress syndrome (RDS) in which a deficiency of surfactant in the lungs results in labored breathing, lung collapse, and hypoxemia.
Jones, Kelly
core +1 more source
Abstract Aim Our aim was to investigate the impact that low‐grade intraventricular haemorrhage (IVH) had on neonatal morbidities, brain volumes and neurodevelopmental outcomes in children born extremely preterm (EPT) and compare them with children born EPT without low‐grade IVH. Methods This prospective cohort study was carried out in Stockholm, Sweden.
Lina Broström+5 more
wiley +1 more source
Early inhaled budesonide for the prevention of bronchopulmonary dysplasia [PDF]
BACKGROUND Systemic glucocorticoids reduce the incidence of bronchopulmonary dysplasia among extremely preterm infants, but they may compromise brain development. The effects of inhaled glucocorticoids on outcomes in these infants are unclear. METHODS We
Aikio O+107 more
core +1 more source
Abstract Aim To assess the feasibility, safety and efficacy of using a high‐flow nasal cannula (HFNC) for stabilising very preterm infants after birth. Methods A prospective observational study included preterm infants born at 28 + 0 to 31 + 6 weeks' gestation between February 2021 and December 2022 at the General University Hospital in Prague ...
Klára Jonáš+4 more
wiley +1 more source
Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites. [PDF]
ObjectiveInhaled nitric oxide (iNO) is a potential new therapy for prevention of bronchopulmonary dysplasia and brain injury in premature infants. This study examined dose-related effects of iNO on NO metabolites as evidence of NO delivery.Study designA ...
Ballard, PL+7 more
core
Bronchopulmonary dysplasia in a premature infant case report and literature review [PDF]
Bronchopulmonary dysplasia is an important cause of morbidity and mortality in premature infants. The aim of this study is to present a premature, extremely low birth weight infant with bronchopulmonary dysplasia.
Frank-Briggs, AI+2 more
core +2 more sources
Mechanisms of bronchopulmonary dysplasia [PDF]
Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants with long term effect on lung function into adulthood. Multiple factors are involved in the development of BPD. This review will summarize the different mechanisms leading to this disease and highlight recent bench and clinical research targeted at understanding the ...
openaire +3 more sources